Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities
- PMID: 11385247
- DOI: 10.1159/000050649
Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities
Abstract
The majority of pancreatic neoplasms show a ductal phenotype and can be classified as ductal adenocarcinomas. Pancreatic duct lesions have been discussed as tumor precursors. This review presents a recently adopted standard system for these lesions which distinguishes among three grades of pancreatic intraepithelial neoplasia (PanIN). Molecular studies revealed that PanIN-2 and PanIN-3 lesions represent a distinct step towards invasive carcinoma. Another focus of the review is the advances that have been made in the further immunohistochemical and molecular characterization of special pancreatic neoplasms showing a ductal phenotype, such as undifferentiated carcinoma, mucinous noncystic (colloid) carcinoma, intraductal papillary mucinous neoplasm, mucinous cystic neoplasm, medullary carcinoma, and other rare tumors.
Copyright 2001 S. Karger AG, Basel
Similar articles
-
Where and when does pancreatic carcinoma start?Med Klin (Munich). 2004 Apr 15;99(4):191-5. doi: 10.1007/s00063-004-1028-3. Med Klin (Munich). 2004. PMID: 15085289
-
WHO-classification 2000: exocrine pancreatic tumors.Verh Dtsch Ges Pathol. 2001;85:219-28. Verh Dtsch Ges Pathol. 2001. PMID: 11894402
-
The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.Curr Gastroenterol Rep. 2004 Apr;6(2):111-8. doi: 10.1007/s11894-004-0037-y. Curr Gastroenterol Rep. 2004. PMID: 15191688 Review.
-
Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.Semin Radiat Oncol. 2005 Oct;15(4):254-64. doi: 10.1016/j.semradonc.2005.04.001. Semin Radiat Oncol. 2005. PMID: 16183479 Review.
-
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6. J Hepatobiliary Pancreat Sci. 2013. PMID: 23475261
Cited by
-
K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.World J Gastroenterol. 2003 Jan;9(1):188-91. doi: 10.3748/wjg.v9.i1.188. World J Gastroenterol. 2003. PMID: 12508380 Free PMC article.
-
Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor.Front Oncol. 2025 Mar 27;15:1551038. doi: 10.3389/fonc.2025.1551038. eCollection 2025. Front Oncol. 2025. PMID: 40236650 Free PMC article.
-
Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.Am J Pathol. 2005 Oct;167(4):959-68. doi: 10.1016/S0002-9440(10)61186-8. Am J Pathol. 2005. PMID: 16192632 Free PMC article.
-
Colloid (mucinous non-cystic) carcinoma of the pancreas: A case report.Oncol Lett. 2015 Nov;10(5):3195-3198. doi: 10.3892/ol.2015.3733. Epub 2015 Sep 21. Oncol Lett. 2015. PMID: 26722311 Free PMC article.
-
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.Am J Pathol. 2002 Nov;161(5):1541-7. doi: 10.1016/S0002-9440(10)64432-X. Am J Pathol. 2002. PMID: 12414502 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical